申请人:EVOLVA SA
公开号:US20140288110A1
公开(公告)日:2014-09-25
1,3-dioxane derivatives are described and their use in the treatment of a disease or condition dependent on PPAR modulation, such as diabetes, cancer, inflammation, neurodegenerative disorders and infections.